3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
46
Leukemia, Lymphocytic, Chronic, B-Cell
18
Myelodysplastic Syndromes
7
Burkitt Lymphoma
7
Waldenstrom Macroglobulinemia
6
Lymphoma, B-Cell, Marginal Zone
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Neoplasms
3
Myeloproliferative Disorders
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Hematologic Neoplasms
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Hairy Cell
1
Interventions
Tretinoin
2
Arsenic Trioxide
2
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
venetoclax
×
30 days
×
Clear all
No trials found.